Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-024253
Filing Date
2019-11-21
Accepted
2019-11-21 06:05:05
Documents
5
Period of Report
2019-11-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k112119_immuronlimited.htm 6-K 13216
2 IMMURON PLANS IMM-124E TRIAL TO PREVENT TRAVELERS' DIARRHEA f6k112119ex99-1_immuron.htm EX-99.1 19744
3 GRAPHIC img_001.jpg GRAPHIC 2985
4 GRAPHIC ex99-1_001.jpg GRAPHIC 19105
5 GRAPHIC ex99-1_002.jpg GRAPHIC 4535
  Complete submission text file 0001213900-19-024253.txt   71063
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 191235636
SIC: 2834 Pharmaceutical Preparations